408
Participants
Start Date
May 15, 2025
Primary Completion Date
May 15, 2030
Study Completion Date
May 15, 2032
Decision Aid
The study intervention is a web-based decision aid (DA) developed by the study team. The Radioactive Iodine Decisions decision aid is designed as an educational tool to help patients have information about Radioactive Iodine and encourage them to talk with their medical team about this treatment decision.
Usual Care
Patients randomized in the Usual Care Condition arm will receive a link for the American Cancer Society website on Radioactive Iodine (Radioiodine) Therapy for Thyroid Cancer as our comparison.
Lombardi Comprehensive Cancer Center, Washington D.C.
MedStar Washington Hospital Center, Washington D.C.
Inova Health System, Falls Church
National Institutes of Health (NIH)
NIH
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Georgetown University
OTHER